Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kaspar Broch

Showing results (51-60 of 97) with videos related to

Pageof 10
Sort By:
Clinical Transplantation|November 22, 2024
The Effect of Everolimus Versus Calcineurin Inhibitors on Quality of Life 10-12 Years After Heart Transplantation: The Results of a Randomized Controlled Trial (SCHEDULE Trial)Ingelin Grov, Anne Relbo Authen, Satish Arora, et al.
Tidsskrift for Den Norske Laegeforening : Tidsskrift for Praktisk Medicin, Ny Raekke|March 27, 2025
Chronic thromboembolic pulmonary hypertensionJohn-Peder Escobar Kvitting, Håvard Ravnestad, Rune Andersen, et al.
Plos One|September 8, 2025
Circulating metabolites in patients with chronic heart failure are not related to gut leakage or gut dysbiosisAndraž Nendl, Sajan C Raju, Peder R Braadland, et al.
Scientific Reports|February 15, 2017
The alternative complement pathway is dysregulated in patients with chronic heart failureNegar Shahini, Annika E Michelsen, Per H Nilsson, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|April 23, 2026
Effect of Interleukin-6 Receptor Inhibition by Tocilizumab on Platelet Activation and Markers of Thrombus Formation: A Substudy of the ASSAIL-MI TrialThor Ueland, Tuva B Dahl, Annika Michelsen, et al.
Frontiers in Cardiovascular Medicine|June 19, 2023
Intestinal fatty acid binding protein is associated with cardiac function and gut dysbiosis in chronic heart failureAndraž Nendl, Sajan C Raju, Kaspar Broch, et al.
The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation|August 22, 2025
Impact of evolocumab on coronary physiology and microstructure in de-novo heart transplant recipientsSalma Raghad Karim, Niels Møller Jensen, Emil Nielsen Holck, et al.
Health and Quality of Life Outcomes|August 19, 2020
High-intensity interval training and health-related quality of life in de novo heart transplant recipients - results from a randomized controlled trialKatrine Rolid, Arne K Andreassen, Marianne Yardley, et al.
Heart (British Cardiac Society)|October 28, 2024
Right ventricular remodelling and long-term survival after pulmonary endarterectomy versus balloon pulmonary angioplasty in chronic thromboembolic pulmonary hypertensionHåvard Ravnestad, Klaus Murbræch, Eyvind Gjønnæss, et al.
American Heart Journal|August 27, 2023
An investigator-sponsored pragmatic randomized controlled trial of AntiCoagulation vs AcetylSalicylic Acid after Transcatheter Aortic Valve Implantation: Rationale and design of ACASA-TAVIChristopher S Dodgson, Jan Otto Beitnes, Sophie F Kløve, et al.
Pageof 10

Showing results (51-60 of 97) with videos related to

Sort By:
Pageof 10
Clinical Transplantation|November 22, 2024
The Effect of Everolimus Versus Calcineurin Inhibitors on Quality of Life 10-12 Years After Heart Transplantation: The Results of a Randomized Controlled Trial (SCHEDULE Trial)Ingelin Grov, Anne Relbo Authen, Satish Arora, et al.
Tidsskrift for Den Norske Laegeforening : Tidsskrift for Praktisk Medicin, Ny Raekke|March 27, 2025
Chronic thromboembolic pulmonary hypertensionJohn-Peder Escobar Kvitting, Håvard Ravnestad, Rune Andersen, et al.
Plos One|September 8, 2025
Circulating metabolites in patients with chronic heart failure are not related to gut leakage or gut dysbiosisAndraž Nendl, Sajan C Raju, Peder R Braadland, et al.
Scientific Reports|February 15, 2017
The alternative complement pathway is dysregulated in patients with chronic heart failureNegar Shahini, Annika E Michelsen, Per H Nilsson, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|April 23, 2026
Effect of Interleukin-6 Receptor Inhibition by Tocilizumab on Platelet Activation and Markers of Thrombus Formation: A Substudy of the ASSAIL-MI TrialThor Ueland, Tuva B Dahl, Annika Michelsen, et al.
Frontiers in Cardiovascular Medicine|June 19, 2023
Intestinal fatty acid binding protein is associated with cardiac function and gut dysbiosis in chronic heart failureAndraž Nendl, Sajan C Raju, Kaspar Broch, et al.
The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation|August 22, 2025
Impact of evolocumab on coronary physiology and microstructure in de-novo heart transplant recipientsSalma Raghad Karim, Niels Møller Jensen, Emil Nielsen Holck, et al.
Health and Quality of Life Outcomes|August 19, 2020
High-intensity interval training and health-related quality of life in de novo heart transplant recipients - results from a randomized controlled trialKatrine Rolid, Arne K Andreassen, Marianne Yardley, et al.
Heart (British Cardiac Society)|October 28, 2024
Right ventricular remodelling and long-term survival after pulmonary endarterectomy versus balloon pulmonary angioplasty in chronic thromboembolic pulmonary hypertensionHåvard Ravnestad, Klaus Murbræch, Eyvind Gjønnæss, et al.
American Heart Journal|August 27, 2023
An investigator-sponsored pragmatic randomized controlled trial of AntiCoagulation vs AcetylSalicylic Acid after Transcatheter Aortic Valve Implantation: Rationale and design of ACASA-TAVIChristopher S Dodgson, Jan Otto Beitnes, Sophie F Kløve, et al.
Pageof 10